Hikari Tsushin, Inc. Amgen Inc Transaction History

Hikari Tsushin, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $5.64 Million - $7.01 Million	-25,811 Reduced 85.01%	4,551 $1.22 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $1.81 Million - $2.04 Million	8,078 Added 36.25%	30,362 $6.84 Million
Q2 2022 Aug 09, 2022	BUY	$230.71 - $256.74 $1.57 Million - $1.74 Million	6,792 Added 43.84%	22,284 $5.42 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $581,942 - $643,780	2,654 Added 20.67%	15,492 $3.75 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $2.55 Million - $2.92 Million	12,838 New	12,838 $2.89 Million

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Hikari Tsushin, Inc., based on Form 13F filings with the SEC.

Stay updated on Hikari Tsushin, Inc. with notifications on news.